Health Trials

Second Trimester Abortion With Letrozole and Misoprostol Compared to Misoprostol Alone

ConditionsAbortion Induced ComplicatedAbortion
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorSohag University

About this trial

Termination of Second trimester Abortion with Letrozole and Misoprostol Compared to Misoprostol Alone

Eligibility criteria

Qualifiers

Pregnant women aged 18-45 years.

Failed pregnancy.

Gestational age between 14 and 20weeks, confirmed by ultrasonography on the day of admission.

Hemoglobin concentration >9 g/dL.

Disqualifiers

Previous attempt to terminate the current pregnancy.

Molar pregnancy (hydatidiform mole).

Pathological uterine lesions including uterine fibroids and congenital uterine malformations.

Cardiac disease.

Trial design

Treatments tested in this trial

  • · Misoprostol + letrozole
  • misoprostol alone

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Sohag University

Lead sponsor

Source ClinicalTrials.gov